On Tuesday, FibroGen Inc (NASDAQ:FGEN)’s shares declined -0.35% to $23.08.
FibroGen Inc (FGEN) was a big mover last session with its shares rising over 8% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This breaks the recent trend of the company as the stock is now trading above the past one month’s volatile price range of $17.36 to $20.59.
This research-based biopharmaceutical company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn’t been in trend either. Friday’s jump is encouraging though, so make sure to keep a close watch on this firm in the near future.
FibroGen, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes therapeutic agents to treat serious unmet medical needs. It is developing roxadustat, or FG-4592, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases (HIF-PHs) that is in Phase III clinical development for the treatment of anemia in chronic kidney disease; FG-3019, a monoclonal antibody in Phase II clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, and liver fibrosis; and FG-5200 for the treatment of corneal blindness resulting from partial thickness corneal damage.
At the end of Tuesday’s trade, Ericsson (ADR) (NASDAQ:ERIC)‘s shares surged 1.44% to $11.28.
The global cost and efficiency program, declared at Ericsson`s (ERIC) Capital Markets Day on November 13, 2014, is progressing according to plan. The ambition is to achieve savings of about SEK 9 b., with full effect during 2017.
As part of the global program, on March 11, 2015, Ericsson declared that 2,200 positions in Sweden, mainly in R&D and Supply, were subject to notice. As the next step of this activity, individuals on different locations in Sweden have been given notice during June. In total, there will be a reduction of about 2,100 positions, with some 1,700 employees leaving the company.
For Q2 2015 restructuring costs of about SEK 2.5 b. are predictable. These estimated costs comprise normal ongoing restructuring in addition to charges related to the cost and efficiency program, this quarter primarily driven by changes in Sweden. Savings related to this specific activity will start to impact results towards the end of 2015.
Ericsson provides communications technology and services worldwide. The company’s Networks segment delivers products and solutions for mobile access, Internet protocol (IP) and transmission networks, core networks, and cloud. This segment offers radio access solutions; IP routing and transport solutions; transmission/backhaul solutions comprising microwave and optical transmission solutions for mobile and fixed networks; IP multimedia subsystem solutions; and operations support systems, in addition to supports operators administration of existing networks. Its Global Services segment delivers managed services, such as services for designing, building, operating, and managing networks or solutions; maintenance; network sharing solutions; shared solutions; and managed services of IT environments, in addition to provides broadcast and media services.
Janus Capital Group Inc (NYSE:JNS), ended its Tuesday’s trading session with -0.39% loss, and closed at $17.79.
Janus Capital Group Inc (JNS) said on Tuesday it launched a total return fund that invests across global stock and bond markets, developed in part by Nobel Prize winner Myron Scholes whom the firm hired 11 months ago.
Ashwin Alankar, Janus’ global head of asset allocation and risk administration and Enrique Chang, the firm’s chief investment officer of equities and asset allocation, will manage the Janus Adaptive Global Allocation Fund, said the Denver-based investment firm with $189.7 billion in assets.
Janus Capital Group, Inc. is a publicly owned asset administration holding company with about $167.7 billion in assets under administration. It also provides retirement planning, investment planning, tax planning, investment for college, and tax planning services to its clients. The firm primarily provides its services to investment companies, retail investors, institutions, and individuals.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
